Aprea Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of APRE for the last quarter is 561.57 k USD, and it's 47.56% higher compared to the previous quarter. The net income of Q2 24 is -3.47 M USD.